CaniNectar Featured in Vet Times: Encouraging Results from Our Professional Field Trial

We are delighted to share that CaniNectar has been featured in Vet Times, one of the UK’s leading sources of news and information for the veterinary profession.

The article, written by Chris Simpson, highlights the encouraging findings from our two-phase professional field trial and the consistent patterns observed across two independently conducted phases.

We would like to thank Vet Times for featuring this important work and Chris Simpson for taking the time to report on our research. It is wonderful to see growing interest in the relationship between canine digestive health, the gut microbiome and wider wellbeing.

About the CaniNectar trial

The trial involved 129 dogs, assessed by 63 UK veterinary professionals, dog trainers and canine behaviourists. It was conducted in two separate phases across 2025 and 2026, using different groups of dogs and different participating professionals.

This independent two-phase design was particularly valuable because it allowed us to explore whether similar patterns would emerge when the trial was repeated months later in a new group.

Participants recorded real-world observations across several measures, including stool quality, digestive signs and behaviour, before and during CaniNectar use.

What did the trial find?

The results revealed several encouraging patterns:

• Approximately 70% of dogs were recorded as showing an improvement in stool quality during the trial.
• Among the 42 dogs that entered the trial with elevated anxiety scores, 38 were recorded as improved, while one was rated as worse.
• Mean anxiety scores in this subgroup fell from 4.29 to 3.23 on the five-point scale used—an approximate reduction of 24.7%.
• The mean reduction in anxiety score was highly similar across the two independent phases: 1.04 points in phase one and 1.10 points in phase two.

The consistency between the two phases is especially interesting. Each phase involved different dogs and different professionals and was conducted months apart, yet a very similar behavioural pattern was observed both times.

The Vet Times article also highlighted findings from a separate four-week trial conducted with Blue Cross rescue dogs in 2025. In that study, 80% of dogs reached ideal stool consistency by week four, compared with 41.7% at the beginning. Improvements were also observed across measures including noise reactivity, skin condition and focus.

A promising foundation for future research

These findings are exciting, but it is important to interpret them carefully. The professional field trial was observational rather than a randomised, blinded and placebo-controlled clinical study. This means the results identify meaningful patterns and support further investigation, but they do not prove that CaniNectar alone caused the changes observed.

For us, the significance lies not in any single figure, but in the fact that similar findings appeared independently across two groups of dogs assessed by different professionals. Together with our wider laboratory, microbiome and real-world research, these results add to a growing body of evidence and give us a strong foundation for further controlled study.

We are excited about what the future holds for CaniNectar and for continued research into the connection between canine digestive health and wider wellbeing. We remain committed to following the science, communicating our findings transparently and building a clearer understanding of how nutritional support may contribute to dogs’ everyday health.

Once again, our sincere thanks to Vet Times and Chris Simpson for sharing our work with the veterinary community.

You can read the full Vet Times feature here.

To explore the study in more detail, visit our two-phase professional field trial page, or discover more of the science behind CaniNectar.